Finally listened to the Q1 announcement webcast over the weekend
- interesting to note that MSB expects both phase 3 readouts within a couple of weeks.
- webcast also seems to suggest that COVID ARDS readouts will trigger a significant proportion of the $505 million pre-commercialisation payments. Along those lines, I'd be expecting a milestone payment to be triggered once we get the 60% interim irrespective as to whether it is overwhelming efficacy or not (just needs to pass futility)
If we assumed COVID ARDS was $200 million of the 505 million, then it might be
- 60% interim (passes futility) - $20 million
- trial completion/overwhelming effiacy $50 million
- EUA - $50 million
- final BLA approval - $ 50 million
- additional markets ie EU - $30 million
All cause ARDS would be similar but with additional milestones along the lines of commencement of phase 3, earlier interims etc
Anyone have a sneaky suspicion that MSB might try to time one of the announcements with tomorrows AGM?![]()
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast Corporate Update and Financial Results Webcast
Ann: Mesoblast Corporate Update and Financial Results Webcast, page-52
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
99.5¢ |
Change
-0.070(6.57%) |
Mkt cap ! $1.136B |
Open | High | Low | Value | Volume |
$1.04 | $1.04 | 99.5¢ | $3.980M | 3.944M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 56239 | 99.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.00 | 103125 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 56239 | 0.995 |
11 | 88118 | 0.990 |
3 | 28311 | 0.985 |
9 | 97667 | 0.980 |
4 | 43265 | 0.975 |
Price($) | Vol. | No. |
---|---|---|
1.000 | 103125 | 2 |
1.005 | 30000 | 1 |
1.010 | 93156 | 7 |
1.015 | 38710 | 2 |
1.020 | 107691 | 4 |
Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |